Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

2.0K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
2.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

423
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
423
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Infertility in Females01:28

Infertility in Females

378
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
378

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychometric properties of the Spanish structured interview of personality organization revised (STIPO-R) in a clinical and community sample.

Borderline personality disorder and emotion dysregulation·2026
Same author

The Current Landscape of Artificial Intelligence in Positron Emission Tomography (PET) Imaging Across the Cancer Continuum.

Journal of clinical medicine·2026
Same author

Adjuvant immunotherapy for muscle-invasive urothelial carcinoma: Considerations for targeting patients.

Bladder cancer (Amsterdam, Netherlands)·2026
Same author

Cancer Reversion Therapy: Prospects, Progress and Future Directions.

Current issues in molecular biology·2026
Same author

A multi-modal approach for decision making in bladder cancer.

Nature reviews. Urology·2026
Same author

Redefining Chemotherapy-Related Headaches: From Pathobiology to Differential Diagnosis and Management.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Aug 25, 2025

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.2K

Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy.

Aruni Ghose1,2,3, Anita Bolina4, Ishika Mahajan5

  • 1Department of Medical Oncology, Barts Cancer Centre, St. Bartholomew's Hospital, Barts Health NHS Trust, London E1 1BB, UK.

International Journal of Environmental Research and Public Health
|October 14, 2022
PubMed
Summary

Hereditary ovarian cancer (HOC) prevention strategies are crucial due to the disease's high mortality. This review explores risk-reducing interventions (RRIs) for high-risk women, comparing their clinical and economic effectiveness.

Keywords:
BRCAcost effectivenessgenetic testingguidelinesovarian cancerrisk-reducing surgery

More Related Videos

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

6.1K
Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

12.4K

Related Experiment Videos

Last Updated: Aug 25, 2025

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.2K
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

6.1K
Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

12.4K

Area of Science:

  • Gynecologic Oncology
  • Cancer Genetics
  • Health Economics

Background:

  • Ovarian cancer (OC) is a lethal gynecologic malignancy with poor prognosis and late-stage presentation.
  • Approximately 25% of OC cases have a hereditary predisposition, often linked to BRCA1/BRCA2 mutations.
  • Women with BRCA mutations face a significantly increased lifetime risk of OC, typically high-grade serous pathology.

Purpose of the Study:

  • To provide an overview of hereditary ovarian cancer (HOC).
  • To explore various risk-reducing interventions (RRIs) for HOC.
  • To compare the cost-effectiveness of HOC prevention strategies for high-risk women.

Main Methods:

  • Review of existing literature on HOC and its prevention.
  • Analysis of current guidelines for hereditary cancer management.
  • Comparative assessment of clinical and economic outcomes of different RRIs.

Main Results:

  • Hereditary ovarian cancer (HOC) requires targeted prevention strategies.
  • Current RRIs include genetic counseling, surgical management, and chemoprophylaxis.
  • Evidence for sporadic OC prevention is more abundant than for the hereditary subgroup.

Conclusions:

  • A targeted, cost-effective approach to HOC prevention is paramount for improving outcomes.
  • Further research is needed to determine the most prudent and economically effective prevention strategy for high-risk women.
  • Comparing RRIs with general population costs is essential for informed decision-making.